Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Amsa S.p.A. is an established Italian pharmaceutical company founded in 1953 that specializes in the development and manufacturing of active pharmaceutical ingredients (APIs) and finished dosage forms. Based in the Milan and Como regions, the company operates as a key manufacturing pillar within the CFM Group, supplying niche pharmaceutical products to over 50 countries worldwide. Amsa's portfolio is particularly strong in corticosteroids, antivirals, and respiratory treatments, featuring well-known products such as Urbason (methylprednisolone) and amantadine. The company maintains high regulatory standards with multiple FDA and EDQM approvals, positioning itself as a reliable partner for both generic and branded pharmaceutical firms. In addition to its own product line, Amsa provides custom synthesis and contract manufacturing services, leveraging its extensive chemical synthesis capabilities to support global drug supply chains.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Amsa.